Semisynthesis of linarin, acacetin, and 6-iodoapigenin derivatives from diosmin

Journal of Natural Products

Volumn 67, Issue 9, 2004, Pages 1624-1627

  Quintin, Jérôme ^a   Lewin, Guy ^a  

^a UNIVERSITÉ PARIS SUD   (France)

Author keywords

[No Author keywords available]

Indexed keywords

6 IODOAPIGENIN; ACACETIN; APIGENIN DERIVATIVE; DIOSMIN; GLYCOSIDE; HESPERIDIN; LINARIN; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CHEMICAL MODIFICATION; CRYSTALLIZATION; DEHYDROGENATION; DERIVATIZATION; DRUG ISOLATION; DRUG SYNTHESIS; HERBAL MEDICINE; HYDROGENOLYSIS; MULTIDRUG RESISTANCE; NONHUMAN; SYNTHESIS;

BIFLAVONOIDS; CITRUS; DIOSMIN; FLAVONES; FLAVONOIDS; GLYCOSIDES; MOLECULAR STRUCTURE; PLANTS, MEDICINAL;

CITRUS;

EID: 4644328883     PISSN: 01633864     EISSN: None     Source Type: Journal    
DOI: 10.1021/np040079b     Document Type: Article

References (26)

1. Innokem FR Patent 2 782 518, 1998, and references within.
2. Ferté, J.; Kühnel, J.-M.; Chapuis, G.; Rolland, Y.; Lewin, G.; Schwaller, M. J. Med. Chem. 1999, 42, 478-489.
3. Adir et Cie EP Patent 832 886, 1997.
4. (a) Martinez-Vazquez, M.; Ramirez Apan, T. O.; Hidemi Aguilar, M.; Bye, R. Planta Med. 1996, 62, 137-140.
5. (b) Martinez-Vazquez, M.; Ramirez Apan, T. O.; Lastra A. L.; Bye, R. Planta Med. 1998, 64, 134-138.
6. Han, S.; Sung, K.-H.; Yim, D.; Lee, S.; Lee, C.-K.; Ha, N.-J.; Kim, K. Arch. Pharm. Res. 2002, 25, 170-177.
7. Fernandez, S.; Wasowski, C.; Paladini, A. C.; Marder, M. Pharmacol. Biochem. Behav. 2004, 77, 399-404.
8. (a) Zembower, D. E.; Zhang, H. J. Org. Chem, 1998, 63, 9300-9305.
9. (b) Lin, Y.-M.; Zembower, D. E.; Flavin, M. T.; Schure, R.; Zhao, G.-X. US Patent 6 399 654.
10. (a) Cacchi, S.; Ciattini, P. S.; Morera, E.; Ortar, G. Tetrahedron Lett. 1986, 27, 5541-5544.
11. (b) Wang, F.; Chiba, K.; Tada, M. J. Chem. Soc., Perkin Trans. 1 1992, 1897-1900.
12. (c) Ritter, K. Synthesis 1993, 735-762.
13. (d) Kotsuki, H.; Datta, P. K.; Hayakawa, H.; Suenaga, H. Synthesis 1995, 1348-1350.
14. (e) Lipshutz, B. H.; Buzard, D. J.; Vivian, R. W. Tetrahedron Lett. 1999, 40, 6871-6874.
15. Musliner, W. J.; Gates, J. W., Jr. J. Am. Chem. Soc. 1966, 88, 4271-4273.
16. (a) Musliner, W. J.; Gates, J. W., Jr. J. Org. Synth. Coll. 1988, 6, 150-152.
17. (b) Entwistle, I. D.; Hussey, B. J.; Johnstone, R. A. W. Tetrahedron Lett. 1980, 21, 4747-4748.
18. (b) Lowe, J. A.; Ewing, F. E.; Drozda, S. E. Synth. Commun. 1989,19, 3027-3035.
19. (c) De Meyer, N.; Haemers, A.; Mishra, L.; Pandey, H.-K.; Pieters, L. A. C.; Vanden Berghe, D. A.; Vlietinck, A. J. J. Med. Chem. 1991, 34, 736-746.
20. Kajigaeshi, S.; Kakinami, T.; Yamasaki, H.; Fujisaki, S.; Kondo, M.; Okamoto, T. Chem. Lett. 1987, 2109-2112.
21. Quintin, J.; Lewin, G. Tetrahedron Lett. 2004, 45, 3635-3638.
22. Lewin, G.; Bert, M.; Dauguet, J.-C.; Schaeffer, C.; Guinamant, J.-L.; Volland, J.-P. Tetrahedron Lett. 1989, 30, 7049-7052.
23. de la Mare, P. B. D.; Swedlund, B. E. In The Chemistry of the Carbon-Halogen Chain; Patai, S., Ed.; John Wiley & Sons: New York, 1973; Chapter 7, pp 522-526.
24. (a) Itokawa, H.; Suto, K.; Takeya, K. Chem. Pharm. Bull. 1981, 29, 1777-1779.
25. (b) Matsuda, H.; Cai, H.; Kubo, M.; Tosa, H.; Iinuma, M. Biol. Pharm. Bull. 1995, 18, 463-466.
26. Bouktaib, M.; Lebrun, S.; Atmani, A.; Rolando, C. Tetrahedron 2002, 58, 10001-10009.